US 11,873,515 B2
Dehydrogenase mutant L283V/L286V, and preparation method and use thereof
Jiajun Huang, Foshan (CN); Rongxu Li, Foshan (CN); Ziying Wu, Foshan (CN); Haoxuan Hu, Foshan (CN); Shaoyu Bai, Foshan (CN); David Zhou, Foshan (CN); and Tony Lu, Foshan (CN)
Assigned to GOLDEN HEALTH (GUANGDONG) BIOTECHNOLOGY CO., LTD., Foshan (CN); and TF BIOSYN BIOTECHNOLOGY CO., LTD., Foshan (CN)
Filed by GOLDEN HEALTH (GUANGDONG) BIOTECHNOLOGY CO., LTD., Foshan (CN); and TF BIOSYN BIOTECHNOLOGY CO., LTD., Foshan (CN)
Filed on Nov. 18, 2022, as Appl. No. 18/056,728.
Claims priority of application No. 202111369684.9 (CN), filed on Nov. 18, 2021.
Prior Publication US 2023/0193217 A1, Jun. 22, 2023
Int. Cl. C12N 9/02 (2006.01); C12N 15/70 (2006.01); C12P 17/16 (2006.01)
CPC C12N 9/0008 (2013.01) [C12N 15/70 (2013.01); C12P 17/165 (2013.01); C12Y 102/04001 (2013.01)] 8 Claims
 
1. A dehydrogenase mutant comprising the amino acid sequence as shown in SEQ ID NO: 1.